A
AXCELIS TECHNOLOGIES INC
ACLSCIK 0001113232NasdaqLarge AcceleratedSpecial Industry Machinery, NecDelawareFY ends Dec 31
Period
FY 2025
Revenue
$839.05M
Net Income
$120.24M
Total Assets
$1.36B
Equity
$1.03B
Shares Out
30.72M
Op. Cash Flow
$118.31M
Business
AXCELIS TECHNOLOGIES INC designs, manufactures and services ion implantation and related processing equipment used in semiconductor chip fabrication. It offers the Purion family of single-wafer implanters, Ovation batch implanters, the Purion Power Series for power devices and a wide range of aftermarket lifecycle products and services including used tools, spare parts, upgrades, maintenance, training and digital remote-support offerings. The company operates an equipment systems business alongside its Customer Solutions & Innovation (CS&I) aftermarket division. It sells primarily through a direct global sales force into fabs and OEMs across North America, Europe and Asia.
Summary from filing dated 2025-02-28
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenue | 839 | 1,018 | 1,131 | 920 | 662 | |
| Total cost of revenue | 462 | 563 | 639 | 518 | 376 | |
| Gross profit | 377 | 455 | 491 | 402 | 286 | |
| Research and development | 109 | 105 | 97 | 78 | 65 | |
| Sales and marketing | 65 | 68 | 63 | 54 | 48 | |
| General and administrative | 83 | 70 | 66 | 57 | 46 | |
| Total operating expenses | 258 | 244 | 226 | 189 | 159 | |
| Income from operations | 119 | 211 | 266 | 212 | 127 | |
| Interest income | 21 | 24 | 18 | 5 | 209,000 | |
| Interest expense | −5 | −5 | −5 | −6 | — | |
| Other, net | 3 | 539,000 | −48,000 | −6 | −2 | |
| Total other income | 19 | 19 | 13 | −7 | −7 | |
| Income before income taxes | 138 | 230 | 279 | 205 | 120 | |
| Income tax provision | 18 | 29 | 32 | 22 | 22 | |
| Net income | 120 | 201 | 246 | — | — | |
| Basic | 3.81 | 6.17 | 7.52 | 5.54 | 2.94 | |
| Diluted | 3.8 | 6.15 | 7.43 | 5.46 | 2.88 | |
| Basic weighted average shares of common stock | 32 | 33 | 33 | 33 | 34 | |
| Diluted weighted average shares of common stock | 32 | 33 | 33 | 34 | 34 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 145 | 124 | 167 | 186 | 295 | |
| Short-term investments | 229 | 448 | 339 | 247 | — | |
| Accounts receivable, net | 168 | 203 | 218 | 170 | 104 | |
| Inventories, net | 329 | 282 | 306 | 242 | 195 | |
| Prepaid income taxes | 5 | 6 | — | — | — | |
| Prepaid expenses and other current assets | 67 | 60 | 49 | 33 | 25 | |
| Total current assets | 943 | 1,124 | 1,080 | 878 | 619 | |
| Property, plant and equipment, net | 56 | 54 | 54 | 40 | 35 | |
| Operating lease assets | 29 | 30 | 31 | 12 | 9 | |
| Finance lease assets, net | 14 | 15 | 17 | 18 | 19 | |
| Long-term restricted cash | 11 | 8 | 7 | 752,000 | 757,000 | |
| Deferred income taxes | 80 | 68 | 53 | 32 | 35 | |
| Long-term investments | 182 | — | — | — | — | |
| Other assets | 46 | 51 | 41 | 34 | 34 | |
| Total assets | 1,361 | 1,349 | 1,282 | 1,014 | 753 | |
| Accounts payable | 42 | 47 | 54 | 62 | 38 | |
| Accrued compensation | 34 | 26 | 31 | 36 | 31 | |
| Warranty | 10 | 13 | 14 | 8 | 6 | |
| Income taxes | 11 | — | 6 | 4 | 887,000 | |
| Deferred revenue | 66 | 95 | 165 | 123 | 60 | |
| Current portion of finance lease obligation | 2 | 1 | 2 | 1 | 979,000 | |
| Other current liabilities | 33 | 26 | 13 | 13 | 13 | |
| Total current liabilities | 198 | 208 | 285 | 248 | 150 | |
| Long-term finance lease obligation | 41 | 42 | 44 | 45 | 46 | |
| Long-term deferred revenue | 43 | 44 | 46 | 31 | 8 | |
| Other long-term liabilities | 45 | 43 | 42 | 22 | 10 | |
| Total liabilities | 327 | 336 | 417 | 346 | 214 | |
| Commitments and contingencies (Note 16) | — | — | — | — | — | |
| Common stock, $0.001 par value, 75,000 shares authorized; 30,717 shares issued and outstanding at December 31, 2025; 32,365 shares issued and outstanding at December 31, 2024 | 31,000 | 32,000 | 33,000 | 33,000 | 33,000 | |
| Additional paid-in capital | 533 | 549 | 547 | 550 | 560 | |
| Retained earnings | 504 | 470 | 320 | 119 | −23 | |
| Accumulated other comprehensive loss | −2 | −6 | −2 | −2 | 2 | |
| Total stockholders' equity | 1,035 | 1,013 | 865 | 667 | 539 | |
| Total liabilities and stockholders' equity | 1,361 | 1,349 | 1,282 | 1,014 | 753 |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net income | 120 | 201 | 246 | 183 | 99 | |
| Depreciation and amortization | 18 | 16 | 13 | 12 | 11 | |
| Deferred income taxes | −11 | −16 | −20 | 9 | 20 | |
| Stock-based compensation expense | 21 | 21 | 18 | 13 | 12 | |
| Provision for doubtful accounts | — | 3 | 1 | — | — | |
| Provision for excess and obsolete inventory | 4 | 6 | 5 | 5 | 4 | |
| Accretion of discounts and premiums on short-term and long-term investments | −4 | −12 | −12 | — | — | |
| Unrealized currency gain on foreign denominated transactions | 2 | 8 | 2 | 6 | — | |
| Mark-to-market adjustment on forward exchange contracts | −435,000 | −267,000 | — | — | — | |
| Accounts receivable | 37 | 7 | −51 | −67 | −18 | |
| Inventories | −42 | 6 | −70 | −58 | −39 | |
| Prepaid expenses and other current assets | −5 | −12 | −16 | −7 | −4 | |
| Accounts payable and other current liabilities | 6 | −413,000 | −8 | 31 | 22 | |
| Deferred revenue | −30 | −71 | 56 | 86 | 45 | |
| Income taxes | 13 | −9 | 4 | 3 | 253,000 | |
| Other assets and liabilities | −11 | −6 | −12 | −625,000 | −2 | |
| Net cash provided by operating activities | 118 | 141 | 157 | 216 | 150 | |
| Expenditures for property, plant and equipment and capitalized software | −11 | −12 | −21 | −11 | −9 | |
| Purchases of short-term and long-term investments | −646 | −539 | −389 | — | — | |
| Maturities and sales of short-term investments | 687 | 443 | 309 | — | — | |
| Net cash provided by (used in) investing activities | 30 | −109 | −101 | −257 | −9 | |
| Net settlement on restricted stock grants | −5 | −12 | −17 | −10 | −7 | |
| Repurchase of common stock | −121 | −60 | −52 | −57 | −50 | |
| Proceeds from Employee Stock Purchase Plan purchases | 2 | 2 | 2 | 2 | 1 | |
| Principal payments on finance lease obligation | −1 | −2 | −1 | −987,000 | −763,000 | |
| Proceeds from exercise of stock options | — | — | 25,000 | 1 | 4 | |
| Net cash used in financing activities | −124 | −71 | −68 | −65 | −52 | |
| Effect of exchange rate changes on cash and cash equivalents | 1 | −4 | −139,000 | −2 | 2 | |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 25 | −43 | −12 | −109 | 91 | |
| Interest | 5 | 5 | 5 | 5 | 5 |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro